driven by the PitchBook Platform
Developer of novel antibiotic and research services for monoclonal antibodies. The company focuses on the discovery and development of novel therapeutic antibodies in oncology and immuno-oncology.
You’re viewing a free company profile from the PitchBook Platform. To explore BliNK Biomedical’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.